Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

盐酸达泊西汀片 - NMPA Drug Approval Details

Approvals/NMPA/Dapoxetine Hydrochloride Tablets

Approved

化学药品

Dapoxetine Hydrochloride Tablets

广州白云山医药集团股份有限公司白云山制药总厂🇨🇳 National Medical Products Administration

Approval Date: Dec 30, 2022
Approval ID: 1f808bb9c3bd3ceb
Company: 广州白云山医药集团股份有限公司白云山制药总厂
Type: 化学药品

Approval Details

Approval Id: 1f808bb9c3bd3ceb
Approval Number: 国药准字H20223926
Generic Name: 盐酸达泊西汀片
Generic Name En: Dapoxetine Hydrochloride Tablets
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 30mg（按C₂₁H₂₃NO计）
Reg Date: 2022-12-30
Company Name: 广州白云山医药集团股份有限公司白云山制药总厂
Company Address: 广州市白云区同和街云祥路88号
Production Company Name: 广州白云山医药集团股份有限公司白云山制药总厂
Production Company Address: 广州市白云区同和街云祥路88号
Company Detail Path: /organization/a9f62f287d722e00/yan-zhou-bai-yun-shan-yi-yao-ji-tuan-gu-fen-you-xian-gong-si-bai-yun-shan-zhi-yao-zong-han
Production Company Detail Path: /organization/a9f62f287d722e00/yan-zhou-bai-yun-shan-yi-yao-ji-tuan-gu-fen-you-xian-gong-si-bai-yun-shan-zhi-yao-zong-han

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 30, 2022

Approval ID

1f808bb9c3bd3ceb

Type

化学药品

Back to NMPA Approvals